US Stock MarketDetailed Quotes

Clearmind Medicine (CMND)

Watchlist
  • 3.340
  • 0.0000.00%
Close Jun 12 16:00 ET
  • 3.270
  • -0.070-2.10%
Post 20:01 ET
3.40MMarket Cap-0.01P/E (TTM)

Clearmind Medicine (CMND) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Jan 31, 2026
(FY)Oct 31, 2025
(Q4)Oct 31, 2025
(Q3)Jul 31, 2025
(Q2)Apr 30, 2025
(Q1)Jan 31, 2025
(FY)Oct 31, 2024
(Q4)Oct 31, 2024
(Q3)Jul 31, 2024
(Q2)Apr 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-64.76%-2.08M
2.56%-4.73M
-19.37%-1.29M
3.72%-1.08M
7.91%-1.1M
13.44%-1.27M
22.90%-4.86M
-43.02%-1.08M
18.09%-1.13M
-11.55%-1.19M
Net income from continuing operations
-259.70%-3.85M
26.60%-3.86M
22.26%-687.84K
37.27%-1.31M
13.68%-783.93K
21.65%-1.07M
39.05%-5.25M
78.26%-884.74K
-264.04%-2.09M
56.26%-908.22K
Operating gains losses
26.82%-373.58K
-61.34%-1.13M
120.85%188.09K
-121.81%-142.73K
-61.74%-667.05K
-1,125.20%-510.5K
-130.94%-701.75K
-137.74%-902.17K
235.54%654.49K
-216.21%-412.41K
Depreciation and amortization
10.72%13.33K
-3.33%49.37K
11.52%12.84K
-17.56%12.52K
-23.94%11.97K
39.47%12.04K
-11.19%51.07K
186.58%11.51K
-15.21%15.19K
15.87%15.74K
Deferred tax
----
-32.19%70.45K
-96.58%2.19K
126.23%8.26K
115.86%20.66K
-80.48%39.34K
497.97%103.88K
464.78%64.12K
-374.71%-31.48K
-1,505.67%-130.26K
Other non cash items
3,879.03%50.85K
3,855.70%213.05K
14,253.63%209.85K
-62.00%872
-35.26%1.05K
127,700.00%1.28K
85.28%5.39K
--1.46K
920.00%2.3K
461.38%1.63K
Change In working capital
161.53%91.72K
69.58%-39.57K
-96.24%10.3K
511.90%208.44K
-89.95%-109.24K
49.66%-149.07K
86.57%-130.11K
-28.77%274.11K
88.51%-50.6K
-109.59%-57.51K
-Change in receivables
-202.28%-82.28K
-73.44%17.25K
-80.99%1.93K
153.92%9.31K
254.64%33.24K
-129.09%-27.22K
142.01%64.95K
1,045.75%10.13K
67.65%-17.26K
-122.67%-21.49K
-Change in prepaid assets
20.15%-195.54K
220.38%4.44K
-5.92%74.97K
-11.99%76.61K
-7.86%97.75K
11.44%-244.88K
85.88%-3.69K
-27.86%79.69K
-22.58%87.04K
-75.68%106.08K
-Change in payables and accrued expense
87.78%233.03K
141.69%82.79K
-80.93%35.03K
231.14%159.72K
-519.20%-236.06K
155.81%124.09K
67.99%-198.59K
-34.02%183.69K
63.60%-121.8K
-25.67%-38.12K
-Change in other working capital
12,918.50%136.52K
-2,094.63%-144.05K
-16,760.66%-101.63K
-2,743.35%-37.19K
95.99%-4.17K
-100.98%-1.07K
104.30%7.22K
120.66%610
--1.41K
---103.97K
Cash from discontinued investing activities
Operating cash flow
-64.76%-2.08M
2.56%-4.73M
-19.37%-1.29M
3.72%-1.08M
7.91%-1.1M
13.44%-1.27M
22.90%-4.86M
-43.02%-1.08M
18.09%-1.13M
-11.55%-1.19M
Investing cash flow
Cash flow from continuing investing activities
0
-127.65%-542.02K
-49.67%-524.43K
234.15%112.95K
-354.78%-200K
69.46K
-807.80%-238.1K
-933.20%-350.4K
339.80%33.8K
78.5K
Net PPE purchase and sale
----
----
----
----
----
----
--0
----
----
----
Net investment purchase and sale
--0
-94.38%-528.52K
-49.67%-524.43K
--112.95K
-354.78%-200K
--82.96K
---271.9K
---350.4K
--0
--78.5K
Net other investing changes
----
-139.93%-13.5K
--0
--0
--0
---13.5K
228.88%33.8K
--0
----
----
Cash from discontinued investing activities
Investing cash flow
--0
-127.65%-542.02K
-49.67%-524.43K
234.15%112.95K
-354.78%-200K
--69.46K
-807.80%-238.1K
-933.20%-350.4K
339.80%33.8K
--78.5K
Financing cash flow
Cash flow from continuing financing activities
1,732.25%7.42M
-58.07%2.62M
592.70%2.24M
-102.30%-10.81K
-107.10%-10.3K
-92.39%404.81K
-46.38%6.25M
-86.56%323.21K
1,581.84%469.54K
-95.07%145.13K
Net issuance payments of debt
-13.91%-11.7K
5,283.41%2.21M
22,417.00%2.24M
19.72%-10.81K
19.48%-10.3K
-63.13%-10.27K
-4.07%-42.59K
---10.03K
-35.52%-13.47K
15.88%-12.79K
Net common stock issuance
--7.25M
--0
--0
--0
--0
--0
-80.28%2.19M
-85.44%264.28K
575.39%103.39K
--0
Proceeds from stock option exercised by employees
-55.88%183.12K
-89.89%415.09K
--0
--0
--0
-88.13%415.09K
595.59%4.1M
-88.31%68.95K
--379.62K
--157.92K
Cash from discontinued financing activities
Financing cash flow
1,732.25%7.42M
-58.07%2.62M
592.70%2.24M
-102.30%-10.81K
-107.10%-10.3K
-92.39%404.81K
-46.38%6.25M
-86.56%323.21K
1,581.84%469.54K
-95.07%145.13K
Net cash flow
Beginning cash position
-40.32%3.92M
21.12%6.57M
-54.49%3.5M
-46.15%4.47M
-37.74%5.78M
21.12%6.57M
4,114.84%5.43M
99.61%7.68M
58.34%8.31M
175.60%9.29M
Current changes in cash
773.98%5.33M
-329.26%-2.65M
138.81%428.58K
-57.63%-982.7K
-35.04%-1.31M
-120.53%-791.16K
-78.31%1.16M
-168.25%-1.1M
55.46%-623.4K
-151.73%-969.15K
Effect of exchange rate changes
270.12%2.48K
127.86%3.22K
42.41%-861
291.59%5.51K
100.18%20
-139.11%-1.46K
69.40%-11.55K
96.04%-1.5K
-338.44%-2.88K
-464.36%-10.9K
End cash Position
60.14%9.26M
-40.32%3.92M
-40.32%3.92M
-54.49%3.5M
-46.15%4.47M
-37.74%5.78M
21.12%6.57M
21.12%6.57M
99.61%7.68M
58.34%8.31M
Free cash flow
-64.76%-2.08M
2.56%-4.73M
-19.37%-1.29M
3.72%-1.08M
7.91%-1.1M
13.44%-1.27M
22.90%-4.86M
-43.02%-1.08M
18.09%-1.13M
-11.55%-1.19M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Jan 31, 2026(FY)Oct 31, 2025(Q4)Oct 31, 2025(Q3)Jul 31, 2025(Q2)Apr 30, 2025(Q1)Jan 31, 2025(FY)Oct 31, 2024(Q4)Oct 31, 2024(Q3)Jul 31, 2024(Q2)Apr 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -64.76%-2.08M2.56%-4.73M-19.37%-1.29M3.72%-1.08M7.91%-1.1M13.44%-1.27M22.90%-4.86M-43.02%-1.08M18.09%-1.13M-11.55%-1.19M
Net income from continuing operations -259.70%-3.85M26.60%-3.86M22.26%-687.84K37.27%-1.31M13.68%-783.93K21.65%-1.07M39.05%-5.25M78.26%-884.74K-264.04%-2.09M56.26%-908.22K
Operating gains losses 26.82%-373.58K-61.34%-1.13M120.85%188.09K-121.81%-142.73K-61.74%-667.05K-1,125.20%-510.5K-130.94%-701.75K-137.74%-902.17K235.54%654.49K-216.21%-412.41K
Depreciation and amortization 10.72%13.33K-3.33%49.37K11.52%12.84K-17.56%12.52K-23.94%11.97K39.47%12.04K-11.19%51.07K186.58%11.51K-15.21%15.19K15.87%15.74K
Deferred tax -----32.19%70.45K-96.58%2.19K126.23%8.26K115.86%20.66K-80.48%39.34K497.97%103.88K464.78%64.12K-374.71%-31.48K-1,505.67%-130.26K
Other non cash items 3,879.03%50.85K3,855.70%213.05K14,253.63%209.85K-62.00%872-35.26%1.05K127,700.00%1.28K85.28%5.39K--1.46K920.00%2.3K461.38%1.63K
Change In working capital 161.53%91.72K69.58%-39.57K-96.24%10.3K511.90%208.44K-89.95%-109.24K49.66%-149.07K86.57%-130.11K-28.77%274.11K88.51%-50.6K-109.59%-57.51K
-Change in receivables -202.28%-82.28K-73.44%17.25K-80.99%1.93K153.92%9.31K254.64%33.24K-129.09%-27.22K142.01%64.95K1,045.75%10.13K67.65%-17.26K-122.67%-21.49K
-Change in prepaid assets 20.15%-195.54K220.38%4.44K-5.92%74.97K-11.99%76.61K-7.86%97.75K11.44%-244.88K85.88%-3.69K-27.86%79.69K-22.58%87.04K-75.68%106.08K
-Change in payables and accrued expense 87.78%233.03K141.69%82.79K-80.93%35.03K231.14%159.72K-519.20%-236.06K155.81%124.09K67.99%-198.59K-34.02%183.69K63.60%-121.8K-25.67%-38.12K
-Change in other working capital 12,918.50%136.52K-2,094.63%-144.05K-16,760.66%-101.63K-2,743.35%-37.19K95.99%-4.17K-100.98%-1.07K104.30%7.22K120.66%610--1.41K---103.97K
Cash from discontinued investing activities
Operating cash flow -64.76%-2.08M2.56%-4.73M-19.37%-1.29M3.72%-1.08M7.91%-1.1M13.44%-1.27M22.90%-4.86M-43.02%-1.08M18.09%-1.13M-11.55%-1.19M
Investing cash flow
Cash flow from continuing investing activities 0-127.65%-542.02K-49.67%-524.43K234.15%112.95K-354.78%-200K69.46K-807.80%-238.1K-933.20%-350.4K339.80%33.8K78.5K
Net PPE purchase and sale --------------------------0------------
Net investment purchase and sale --0-94.38%-528.52K-49.67%-524.43K--112.95K-354.78%-200K--82.96K---271.9K---350.4K--0--78.5K
Net other investing changes -----139.93%-13.5K--0--0--0---13.5K228.88%33.8K--0--------
Cash from discontinued investing activities
Investing cash flow --0-127.65%-542.02K-49.67%-524.43K234.15%112.95K-354.78%-200K--69.46K-807.80%-238.1K-933.20%-350.4K339.80%33.8K--78.5K
Financing cash flow
Cash flow from continuing financing activities 1,732.25%7.42M-58.07%2.62M592.70%2.24M-102.30%-10.81K-107.10%-10.3K-92.39%404.81K-46.38%6.25M-86.56%323.21K1,581.84%469.54K-95.07%145.13K
Net issuance payments of debt -13.91%-11.7K5,283.41%2.21M22,417.00%2.24M19.72%-10.81K19.48%-10.3K-63.13%-10.27K-4.07%-42.59K---10.03K-35.52%-13.47K15.88%-12.79K
Net common stock issuance --7.25M--0--0--0--0--0-80.28%2.19M-85.44%264.28K575.39%103.39K--0
Proceeds from stock option exercised by employees -55.88%183.12K-89.89%415.09K--0--0--0-88.13%415.09K595.59%4.1M-88.31%68.95K--379.62K--157.92K
Cash from discontinued financing activities
Financing cash flow 1,732.25%7.42M-58.07%2.62M592.70%2.24M-102.30%-10.81K-107.10%-10.3K-92.39%404.81K-46.38%6.25M-86.56%323.21K1,581.84%469.54K-95.07%145.13K
Net cash flow
Beginning cash position -40.32%3.92M21.12%6.57M-54.49%3.5M-46.15%4.47M-37.74%5.78M21.12%6.57M4,114.84%5.43M99.61%7.68M58.34%8.31M175.60%9.29M
Current changes in cash 773.98%5.33M-329.26%-2.65M138.81%428.58K-57.63%-982.7K-35.04%-1.31M-120.53%-791.16K-78.31%1.16M-168.25%-1.1M55.46%-623.4K-151.73%-969.15K
Effect of exchange rate changes 270.12%2.48K127.86%3.22K42.41%-861291.59%5.51K100.18%20-139.11%-1.46K69.40%-11.55K96.04%-1.5K-338.44%-2.88K-464.36%-10.9K
End cash Position 60.14%9.26M-40.32%3.92M-40.32%3.92M-54.49%3.5M-46.15%4.47M-37.74%5.78M21.12%6.57M21.12%6.57M99.61%7.68M58.34%8.31M
Free cash flow -64.76%-2.08M2.56%-4.73M-19.37%-1.29M3.72%-1.08M7.91%-1.1M13.44%-1.27M22.90%-4.86M-43.02%-1.08M18.09%-1.13M-11.55%-1.19M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
The U.S.-Iran peace talks have entered a critical window! On the 14th, Iranian sources indicated that Pakistan will host a video conference Show More